|Articles|December 1, 2019
- Pharmaceutical Executive-12-01-2019
- Volume 39
- Issue 12
Pharmaceutical Executive, December 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive December 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 6 years ago
Market Access: Employers as Barriers to Valueabout 6 years ago
Lundbeck's Taj Bhardwaj: Market Access and Mental Healthabout 6 years ago
The Route to Market Access in Europeabout 6 years ago
A Multi-Stakeholder Perspective On Assessing Drug Valueabout 6 years ago
When the Patient Loses in Market Accessabout 6 years ago
Making Sense of Copay Accumulatorsabout 6 years ago
Year in Review: R&D, Regulatory, and Reimbursement Hurdlesabout 6 years ago
Who’s Going to Choose Where to Launch a Drug?about 6 years ago
Back to the Basics?about 6 years ago
Focus Report: Puerto RicoNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
JP Morgan 2026 Preview: Eli Lilly Seeks Bounce Back
2
AstraZeneca Reaches $2 Billion License Agreement with Jacobio Pharma for Pan-KRAS Inhibitor
3
Alnylam Announces $250 Million Investment in Massachusetts Facility
4
Pharmaceutical Executive Daily: Nine New Additions to TrumpRx
5